Long-Term Efficacy of Abrocitinib in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE EXTEND. J of Skin 2024, 8 (1), s329. https://doi.org/10.25251/skin.8.supp.329.